U07.0
Vaping-related disorder
Clinical Classification Guidelines
Use Additional Code
- code to identify manifestations, such as:
- abdominal pain (R10.84)
- acute respiratory distress syndrome (J80)
- diarrhea (R19.7)
- drug-induced interstitial lung disorder (J70.4)
- lipoid pneumonia (J69.1)
- weight loss (R63.4)
Inclusion Terms
- Dabbing related lung damage
- Dabbing related lung injury
- E-cigarette, or vaping, product use associated lung injury [EVALI]
- Electronic cigarette related lung damage
- Electronic cigarette related lung injury
Medical Intelligence & Overview
Vaping-related disorder, classified under ICD-10 code U07.0, refers to lung injuries associated with the use of electronic cigarettes and vaping products. Often linked to recent outbreaks of lung illness, this condition results from inhaling vaporized substances that can sometimes contain harmful chemicals. While vaping is often considered a safer alternative to traditional smoking, emerging evidence suggests that it can pose significant health risks, particularly when the devices or substances used are contaminated or improperly manufactured. Recognizing the signs and understanding the potential causes can help users and healthcare providers manage this condition effectively.
Causes & Symptoms
Clinical Causes: Use of unregulated or illicit vaping products containing harmful chemicals Exposure to vitamin E acetate, particularly in THC-containing vaping products Inhalation of other toxic substances or contaminants present in e-liquids Repeated or high-intensity dabbing (high-concentrate THC consumption) Use of devices that overheat or malfunction, releasing dangerous substances
Key Symptoms: Sudden onset of shortness of breath Chest pain or tightness Persistent cough Fatigue and general malaise Fever or chills Gastrointestinal symptoms such as nausea or vomiting Weight loss in severe cases Difficulty breathing or rapid breathing
Diagnostic & Treatment
Diagnosis Path: Diagnosing vaping-related disorder involves a thorough review of the patient's vaping history, including products used and-duration of use. Healthcare professionals may perform physical examinations, chest imaging like X-rays or CT scans, and laboratory tests to rule out infections or other lung conditions. No specific blood test exists for EVALI, but medical teams consider recent vaping activity alongside clinical and imaging findings to establish the diagnosis. It is also critical to exclude other causes of lung injury, such as infections, autoimmune diseases, or exposure to other environmental toxins.
Treatment Protocols: Treatment focuses on supportive care, including oxygen therapy for patients with respiratory distress. Severe cases may require hospitalization with interventions such as corticosteroids to reduce lung inflammation. Patients are advised to cease vaping immediately and avoid exposure to potential harmful substances. In addition, management of any complications, such as secondary infections or lung damage, may be necessary. Long-term follow-up is important to monitor recovery and lung function, especially in those with significant respiratory compromise.
Clinical Advice & FAQs
Billing Guidance
Is U07.0 a billable ICD-10 code?
Yes, U07.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report U07.0?
Clinical documentation must specify the nature of Vaping-related disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference